Bansal B R, Mobini J, Bansal S C
Cancer. 1978 Nov;42(5):2079-96. doi: 10.1002/1097-0142(197811)42:5<2079::aid-cncr2820420502>3.0.co;2-0.
The effect of multimodal immunotherapy was studied in rats bearing primary gastrointestinal tumors induced by 1,2-dimethylhydrazine dihydrochloride. Multimodal immune manipulation consisted of combinations of splenectomy, C. parvum, unblocking serum, unblocked lymphoid cells, and levamisole. Such immunologic intervention resulted in significant inhibition of tumor growth, and their metastasis. Ten of 10 untreated rats, 8 of 8 rats treated with splenectomy alone and 10 of 10 rats treated with normal rabbit serum died of progressive tumor growth. None of the rats treated with combinations of splenectomy, unblocking serum, unblocked lymphoid cells, C. parvum and levamisole succumbed to progressive tumor growth during the observation period. The histologic evidence of tumor destruction was obtained in 18 of 22 tumors in rats of groups receiving multimodal immunotherapy.
在由二盐酸1,2 - 二甲基肼诱导产生原发性胃肠道肿瘤的大鼠中研究了多模式免疫疗法的效果。多模式免疫操作包括脾切除术、微小隐孢子虫、解封血清、解封淋巴细胞和左旋咪唑的联合应用。这种免疫干预导致肿瘤生长及其转移受到显著抑制。10只未治疗的大鼠中有10只、仅接受脾切除术治疗的8只大鼠中有8只以及接受正常兔血清治疗的10只大鼠中有10只死于肿瘤的进行性生长。在接受多模式免疫疗法的大鼠组中,22个肿瘤中有18个获得了肿瘤破坏的组织学证据。